1. Home
  2. CTNT vs CDIO Comparison

CTNT vs CDIO Comparison

Compare CTNT & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$1.73

Market Cap

4.9M

Sector

N/A

ML Signal

HOLD

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$1.84

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
CDIO
Founded
2016
2017
Country
United States
United States
Employees
N/A
17
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.4M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
CTNT
CDIO
Price
$1.73
$1.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
36.5K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
N/A
EPS
N/A
N/A
Revenue
$1,288,536.00
N/A
Revenue This Year
$42.49
$171,906.75
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$0.97
52 Week High
$4.21
$7.91

Technical Indicators

Market Signals
Indicator
CTNT
CDIO
Relative Strength Index (RSI) 49.76 42.11
Support Level $1.48 $1.68
Resistance Level $1.91 $2.16
Average True Range (ATR) 0.18 0.17
MACD 0.01 -0.03
Stochastic Oscillator 53.76 6.38

Price Performance

Historical Comparison
CTNT
CDIO

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: